Spectral AI Net Common Equity Issued/Repurchased 2021-2024 | MDAI
Spectral AI net common equity issued/repurchased from 2021 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
| Spectral AI Annual Net Common Equity Issued/Repurchased (Millions of US $) |
|
|---|---|
| 2024 | $4 |
| 2023 | $4 |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.032B | $0.030B |
| Spectral MD Holdings Ltd. is a predictive AI company focused on medical diagnostics. The Company's DeepView(R) platform is a predictive diagnostic device which offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. Spectral MD Holdings Ltd., formerly known as ROSECLIFF ACQ, is based in DALLAS. | |||